This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2018-2019.
Company Filing History:
Years Active: 2018-2019
Title: Guy Baudoux: Innovator in Immunogenic Compositions
Introduction
Guy Baudoux is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of immunology, particularly in the development of vaccines and immunogenic compositions. With a total of 2 patents, his work has the potential to impact public health positively.
Latest Patents
Baudoux's latest patents include innovative approaches to immunogenic rhinovirus peptides. One patent focuses on fusion proteins that comprise a carrier protein and a Human Rhinovirus (HRV) peptide, along with immunogenic compositions containing these fusion proteins. Another patent provides immunogenic compositions that include human picornavirus peptides derived from the virus's structural proteins. These compositions aim to prevent picornavirus infection and disease, highlighting particular peptides from VP4 and VP1.
Career Highlights
Throughout his career, Baudoux has been associated with GlaxoSmithKline Biologicals SA, where he has contributed to groundbreaking research in vaccine development. His expertise in immunogenic compositions has positioned him as a key figure in the field.
Collaborations
Baudoux has worked alongside talented colleagues such as Mathieu Boxus and Brigitte Colau. Their collaborative efforts have further advanced the research and development of innovative immunogenic solutions.
Conclusion
Guy Baudoux's contributions to immunology through his patents and collaborations underscore his role as an influential inventor in the field. His work continues to pave the way for advancements in vaccine development and public health.